· Stimulates glycolytic metabolism and promotes reprogramming of somatic cells (Zhang et al.).
· Enhances reprogramming of human primary somatic cells to induced pluripotent stem cells (Zhu et al.).
· Induces hypoxia-inducible factor-1α (HIF-1α) and inhibits cell proliferation (Triantafyllou et al.).
· Promotes apoptosis of glioblastoma cells when used together with temozolomide (Sang et al.).
· Reduces tumorigenicity of pancreatic cancer cells (Fan et al.).
This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.